Fast Five Quiz: Type 2 Diabetes Incretin-Based Therapy

Romesh Khardori, MD, PhD; Anne L. Peters, MD

Disclosures

May 16, 2022

The most common side effect that causes drug discontinuation in patients with type 2 diabetes taking GLP-1 RAs is gastrointestinal intolerance. One study noted an increased risk for gallstones or biliary tract-related events with the use of GLP-1 RAs.

GLP-1 RAs are available in oral and injectable formulations.

An increased risk for genital fungal infections and urinary tract infections has been observed with SGLT2 inhibitors; however, most are easily managed. Urinary tract infections have not been observed with the use of DPP-4 inhibitors.

Learn more about type 2 diabetes.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.

processing....